About genomma lab internacional sab de cv - GNMLF
Genomma Lab Internacional SAB de CV engages in the development, manufacturing and marketing of pharmaceutical, beauty and personal care products. The company was founded by Rodrigo Alonso Herrera Aspra on October 30, 1996 and is headquartered in Mexico City, Mexico.
GNMLF At a Glance
Genomma Lab Internacional SAB de CV
Avendia Antonio Dovalí Jaime, 70
Mexico City, Ciudad de Mexico 01210
| Phone | 52-55-5081-0000 | Revenue | 1.02B | |
| Industry | Pharmaceuticals: Major | Net Income | 81.46M | |
| Sector | Health Technology | 2024 Sales Growth | 9.361% | |
| Fiscal Year-end | 12 / 2025 | Employees | 1,605 | |
| View SEC Filings |
GNMLF Valuation
| P/E Current | 9.943 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 14.509 |
| Price to Sales Ratio | 1.165 |
| Price to Book Ratio | 2.257 |
| Price to Cash Flow Ratio | 9.50 |
| Enterprise Value to EBITDA | 5.931 |
| Enterprise Value to Sales | 1.36 |
| Total Debt to Enterprise Value | 0.226 |
GNMLF Efficiency
| Revenue/Employee | 632,458.51 |
| Income Per Employee | 50,752.009 |
| Receivables Turnover | 3.179 |
| Total Asset Turnover | 0.871 |
GNMLF Liquidity
| Current Ratio | 1.845 |
| Quick Ratio | 1.513 |
| Cash Ratio | 0.364 |
GNMLF Profitability
| Gross Margin | 64.122 |
| Operating Margin | 20.989 |
| Pretax Margin | 15.538 |
| Net Margin | 8.025 |
| Return on Assets | 9.785 |
| Return on Equity | 21.106 |
| Return on Total Capital | 13.654 |
| Return on Invested Capital | 14.469 |
GNMLF Capital Structure
| Total Debt to Total Equity | 59.602 |
| Total Debt to Total Capital | 37.344 |
| Total Debt to Total Assets | 28.185 |
| Long-Term Debt to Equity | 46.97 |
| Long-Term Debt to Total Capital | 29.429 |